Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.

@article{Barnabe2009EffectOT,
  title={Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.},
  author={Cheryl Barnabe and David Arthur Hanley},
  journal={Seminars in arthritis and rheumatism},
  year={2009},
  volume={39 2},
  pages={116-22}
}
OBJECTIVES Anti-tumor necrosis factor-alpha (TNFalpha) therapy has proven efficacious in improving both disease activity and focal bone erosions in patients with rheumatoid arthritis (RA) and spondyloarthopathies. We review the current literature reporting on the effect of anti-TNFalpha on bone density as measured by dual energy radiograph absorptiometry at the lumbar spine and hip, as well as markers of bone turnover and resorption, in patients using anti-TNFalpha for rheumatic disease… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Osteoblast Role in Rheumatic Diseases

International journal of molecular sciences • 2017
View 1 Excerpt

Decreased Serotonin Levels and Serotonin-Mediated Osteoblastic Inhibitory Signaling in Patients With Ankylosing Spondylitis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • 2016
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Long term effects of Infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

F Chopin, P Garnero, +3 authors C Roux
Ann Rheum Dis 2007 epub • 2007

Similar Papers

Loading similar papers…